Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
Clinical trial NCT06899204 · RECRUITING
Trial details
- NCT number
- NCT06899204
- Sponsor
- Pfizer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-24
- Primary completion
- 2027-02-15
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.